ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 171 filers reported holding ZOGENIX INC in Q4 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,443,000 | -16.2% | 36,048 | 0.0% | 0.33% | -17.2% |
| Q2 2019 | $1,722,000 | -13.2% | 36,048 | 0.0% | 0.40% | -16.1% |
| Q1 2019 | $1,983,000 | +50.9% | 36,048 | 0.0% | 0.48% | +31.3% |
| Q4 2018 | $1,314,000 | -25.4% | 36,048 | +1.5% | 0.36% | -8.3% |
| Q3 2018 | $1,761,000 | – | 35,508 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 971,875 | $24,034,000 | 14.58% |
| Eversept Partners, LP | 2,013,467 | $49,793,039 | 12.38% |
| Pinz Capital Management, LP | 98,800 | $2,443,000 | 6.40% |
| RA Capital Management | 5,275,538 | $130,464,000 | 4.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,797 | $6,955,000 | 3.17% |
| Granite Point Capital Management, L.P. | 203,462 | $5,032,000 | 2.84% |
| Avoro Capital Advisors LLC | 2,800,000 | $69,244,000 | 2.34% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,029,699 | $25,464,000 | 2.33% |
| Eventide Asset Management | 2,841,300 | $70,265,000 | 2.28% |
| Perceptive Advisors | 3,452,921 | $85,390,000 | 2.22% |